Is CSL publicly listed?

Yes. It trades as ASX:ASX:CSL. Market capitalisation is in the ~A$53B range, recorded as a dated snapshot rather than a live quote.

Is CSL still trading?

CSL is recorded as actively trading.

Company

CSL

ASX:CSL

Plasma immunoglobulins, gene therapy.

At a glance

Listing: ASX:CSL
Category: ASX listed
Headquarters: Melbourne
Market cap: ~A$53B

Thesis

Why it is in this universe

Category: ASX listed
Market: Australia
Recent inflection: Decade-low price; ~US$5B Vifor impairment; demerging Seqirus (flu vaccines) by end FY26.
Services: None recorded
People tracked: None on file

Market data

Listing and scale

Metric	Detail
Exchange	ASX
Ticker	ASX:CSL
Secondary listing	None
Market cap	~A$53B
Status	Listed and trading

Editor's noteA listing or financing event is not a clinical result. variis grades evidence on the linked protocol, not the share price.

Get in touch

Contact

Address: Melbourne
Website: No site on file
Phone: No public number published
Email: No public address published

Offering

What it sells today

No commercial services are recorded for this company yet.

Recent inflection

What moved lately

Decade-low price; ~US$5B Vifor impairment; demerging Seqirus (flu vaccines) by end FY26.

Common questions

Why does variis track CSL?: Plasma immunoglobulins, gene therapy.
Is CSL publicly listed?: Yes. It trades as ASX:ASX:CSL. Market capitalisation is in the ~A$53B range, recorded as a dated snapshot rather than a live quote.
Where is CSL based?: Melbourne
Is CSL still trading?: CSL is recorded as actively trading.

Keep reading

Related coverage from the newsroom.

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

Suggest an update

Sources

What this profile is built on

No source is on file for this company yet. Treat everything above as unverified until one is.

Last updated 14 August 2026

Every entity profile on variis is sourced. Not investment advice.